A Long-term Safety Study of Infliximab (Remicade)

Clinical trial NCT00261976 · COMPLETED

Trial details

NCT number: NCT00261976
Sponsor: Centocor, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis, Rheumatoid Crohn Disease Psoriasis

Start date: 2002-02-01
Primary completion: 2012-03-01
Enrollment: 2971

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.